These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 17229018

  • 1. Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
    Siris ES, Lyles KW, Singer FR, Meunier PJ.
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P94-8. PubMed ID: 17229018
    [Abstract] [Full Text] [Related]

  • 2. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A.
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [Abstract] [Full Text] [Related]

  • 3. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP, Ward LC, Stewart GO, Will RK, Criddle RA, Prince RL, Stuckey BG, Dhaliwal SS, Bhagat CI, Retallack RW, Kent GN, Drury PJ, Vasikaran S, Gutteridge DH.
    Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
    [Abstract] [Full Text] [Related]

  • 4. Treatment of Paget's disease of bone: a survey of clinical practice in Australia.
    Walsh JP, Attewell R, Stuckey BG, Hooper MJ, Wark JD, Fletcher S, Ferrari V, Eisman JA.
    Bone; 2008 Jun; 42(6):1219-25. PubMed ID: 18353737
    [Abstract] [Full Text] [Related]

  • 5. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
    Stuckey BG, Lim EM, Kent GN, Ward LC, Gutteridge DH.
    J Bone Miner Res; 2001 Sep; 16(9):1719-23. PubMed ID: 11547843
    [Abstract] [Full Text] [Related]

  • 6. Paget's disease of bone.
    Siris ES.
    J Bone Miner Res; 1998 Jul; 13(7):1061-5. PubMed ID: 9661069
    [Abstract] [Full Text] [Related]

  • 7. Management of Paget's disease of bone.
    Langston AL, Ralston SH.
    Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244
    [Abstract] [Full Text] [Related]

  • 8. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
    Rendina D, Mossetti G, Viceconti R, Sorrentino M, Nunziata V.
    Calcif Tissue Int; 2004 Sep; 75(3):189-96. PubMed ID: 15148558
    [Abstract] [Full Text] [Related]

  • 9. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
    Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D.
    N Engl J Med; 2005 Sep 01; 353(9):898-908. PubMed ID: 16135834
    [Abstract] [Full Text] [Related]

  • 10. Bisphosphonate resistance in Paget's disease of bone.
    Joshua F, Epstein M, Major G.
    Arthritis Rheum; 2003 Aug 01; 48(8):2321-3. PubMed ID: 12905487
    [Abstract] [Full Text] [Related]

  • 11. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
    Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR.
    J Bone Miner Res; 2007 Jan 01; 22(1):142-8. PubMed ID: 17032148
    [Abstract] [Full Text] [Related]

  • 12. Bisphosphonates in the treatment of disorders of mineral metabolism.
    Singer FR, Minoofar PN.
    Adv Endocrinol Metab; 1995 Jan 01; 6():259-88. PubMed ID: 7671099
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological therapy of Paget's and other metabolic bone diseases.
    Hosking D.
    Bone; 2006 Feb 01; 38(2 Suppl 2):S3-7. PubMed ID: 16406763
    [Abstract] [Full Text] [Related]

  • 14. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE.
    Arch Intern Med; 1989 Dec 01; 149(12):2765-7. PubMed ID: 2596945
    [Abstract] [Full Text] [Related]

  • 15. Paget's disease of bone: experience from a centre in southern India.
    Anjali, Thomas N, Rajaratnam S, Shanthly N, Oommen R, Seshadri MS.
    J Assoc Physicians India; 2006 Jul 01; 54():525-9. PubMed ID: 17089899
    [Abstract] [Full Text] [Related]

  • 16. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
    Polyzos SA, Anastasilakis AD, Makras P, Terpos E.
    Exp Clin Endocrinol Diabetes; 2011 Oct 01; 119(9):519-24. PubMed ID: 21811962
    [Abstract] [Full Text] [Related]

  • 17. Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate.
    Schweitzer DH, Zwinderman AH, Vermeij P, Bijvoet OL, Papapoulos SE.
    J Bone Miner Res; 1993 Feb 01; 8(2):175-82. PubMed ID: 8442435
    [Abstract] [Full Text] [Related]

  • 18. Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone.
    Merlotti D, Gennari L, Martini G, Valleggi F, De Paola V, Avanzati A, Nuti R.
    J Bone Miner Res; 2007 Oct 01; 22(10):1510-7. PubMed ID: 17605632
    [Abstract] [Full Text] [Related]

  • 19. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS, Fayans EP.
    Todays FDA; 2008 Aug 01; 20(8):38-41, 43-6. PubMed ID: 18767452
    [Abstract] [Full Text] [Related]

  • 20. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L, Peris P, Guañabens N, Vidal S, Quintó L, Monegal A, Pons F, Ballesta AM, Muñoz-Gómez J.
    Rheumatology (Oxford); 2004 Jul 01; 43(7):869-74. PubMed ID: 15054158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.